Empirical Meropenem Versus Piperacillin/Tazobactam for Adult Patients With Sepsis
Condition(s):Sepsis; Septic ShockLast Updated:January 11, 2024Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Sepsis; Septic ShockLast Updated:January 11, 2024Not yet recruiting
Condition(s):Covid19; HypoxiaLast Updated:February 24, 2022Completed
Condition(s):DeliriumLast Updated:March 19, 2024Completed
Condition(s):Covid-19; HypoxiaLast Updated:September 21, 2021Completed
Condition(s):Septic ShockLast Updated:October 3, 2014Completed
Condition(s):ICU PatientsLast Updated:June 17, 2009Terminated
Condition(s):Septic ShockLast Updated:April 20, 2022Active, not recruiting
Condition(s):Gastrointestinal Bleeding; Stress UlcersLast Updated:November 15, 2022Completed
Condition(s):Septic Shock; SepsisLast Updated:December 9, 2015Completed
Condition(s):Severe Sepsis; Septic ShockLast Updated:July 10, 2012Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.